{"brief_title": "A Long-term Safety Study of Once-daily Travatan", "brief_summary": "Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension.", "condition": ["Glaucoma, Open-angle", "Ocular Hypertension"], "intervention_type": ["Drug"], "intervention_name": ["Travatan"], "description": ["Travoprost (0.004%) 1 drop each eye once daily"], "arm_group_label": ["Travatan"], "criteria": "Adult patients of any race and either sex with chronic angle-closure glaucoma.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "OHT", "mesh_term": ["Glaucoma", "Ocular Hypertension", "Glaucoma, Open-Angle", "Travoprost"], "id": "NCT00051168"}